by Team Small News | May 31, 2025 | Cipla, Pharma
The US Food and Drug Administration (USFDA) has issued a single observation for Cipla’s Bommasandra facility, which is a pharmaceutical manufacturing plant located in Karnataka, India. The observation was made after the USFDA conducted an inspection of the... by Team Small News | May 18, 2025 | Cipla, Pharma
Amit Patel has been promoted to Head of Consumer Marketing Excellence at Cipla India, a leading pharmaceutical company. In his new role, Patel will be responsible for driving consumer marketing across various therapeutic areas, with a focus on building patient-centric... by Team Small News | May 9, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma
The India Active Pharmaceutical Ingredients (API) market is expected to experience significant growth, with an estimated value of USD 14.81 billion in 2025 and a projected value of USD 25.23 billion by 2032, at a compound annual growth rate (CAGR) of 7.9%. This growth... by Team Small News | May 9, 2025 | Cipla, Pharma
Cipla EMEU and Cipla Limited have been recognized at the Healthcare Asia Pharma Awards 2025 for their innovative initiatives. Cipla EMEU received the ESG Program of the Year – India award for its Ahead & Apart campaign, which promotes sustainable practices... by Team Small News | Apr 10, 2025 | Cipla, Pharma
Pharmaceutical company Cipla has announced the date for its earnings release for the fourth quarter and full year ended March 31, 2025. The company’s Board of Directors is scheduled to meet on Tuesday, May 13, 2025, to consider and approve the standalone and... by Team Small News | Apr 2, 2025 | Cipla, Lupin, Pharma
The latest survey on the Doxorubicin market has been conducted to provide a comprehensive analysis of the market’s performance, competitive environment, and market size. The report covers the period from 2019 to 2024 and provides a forecast till 2031. The market...